MIR3202-1

Across TCGA pan-cancer cohorts, MIR3202-1 RNA is linked to patient survival in 20 of 34 cancer types, making it the most broadly survival-associated MIR3202-1 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher MIR3202-1 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR3202-1 expression acts as an unfavorable survival marker, although some lineages such as BLCA and LIHC show a favorable association.

KIRC, KIRP, and CESC are the cancer types where MIR3202-1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	OS	Quartile	II,III,IV	0.324	0.570	<.001	62	view →
KIRP	OS	Tertile	III,IV	0.370	0.730	<.001	54	view →
CESC	DFS	Tertile	All	0.729	0.860	.001	34	view →
LGG	DFS	Tertile	All	0.753	0.876	<.001	31	view →
LUAD	DFS	Tertile	IV	0.407	0.788	.012	24	view →
READ	DFS	Tertile	II,III,IV	0.341	0.749	.014	17	view →
COAD	DFS	Quartile	All	0.293	0.602	.007	16	view →
PRAD	DFS	Tertile	All	0.818	0.909	.003	16	view →
UVM	DFS	Tertile	III,IV	0.301	0.632	.007	14	view →
CHOL	DFS	Tertile	II,III,IV	0.097	0.490	.026	13	view →
MESO	DFS	Tertile	II,III,IV	0.296	0.536	.030	12	view →
BLCA	DFS	Median	IV	0.495	0.283	.004	11	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 20 lineages.

MIR3202-1–KIRC (OS)

Open the KIRC breakdown →